7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-06-30 2024-03-31 2023-12-31 2023-06-30 2023-03-31 2022-12-31 2022-06-30 2022-03-31 2021-12-31 2021-06-30 2021-03-31 2020-12-31 2020-03-31 2019-12-31 2015-12-31 2015-06-30 2015-03-31 2011-06-30 
                         
      first nine months
    		                     
      cash flows from operating activities
    		                     
      net income
    		444,000,000 473,000,000 1,831,000,000 3,167,000,000 1,334,000,000 -523,000,000 3,679,000,000 1,663,000,000 1,259,000,000 -2,481,000,000 -3,119,000,000  3,815,000,000 3,262,000,000  -1,993,000,000 -1,672,000,000     
      depreciation and tooling amortization
    		3,747,000,000 1,848,000,000 1,931,000,000 3,795,000,000 1,881,000,000 2,012,000,000 3,775,000,000 1,897,000,000 1,973,000,000 3,774,000,000 1,857,000,000 1,840,000,000 3,639,000,000 2,103,000,000 2,081,000,000 2,444,000,000 2,379,000,000     
      other amortization
    		-929,000,000 -464,000,000 -481,000,000 -772,000,000 -376,000,000 -314,000,000 -554,000,000 -272,000,000 -273,000,000 -608,000,000 -310,000,000 -324,000,000 -715,000,000 -361,000,000 -356,000,000 -302,000,000 -308,000,000     
      provision for credit and insurance losses
    		323,000,000 161,000,000 142,000,000 317,000,000 126,000,000 89,000,000 212,000,000 83,000,000 116,000,000 -107,000,000 -66,000,000  -196,000,000 -36,000,000  598,000,000 121,000,000     
      pension and other postretirement employee benefits
    		187,000,000 94,000,000 -540,000,000 201,000,000 166,000,000 2,026,000,000 612,000,000 303,000,000     -808,000,000         
      equity method investment losses and impairments in excess of dividends received
    		261,000,000 -14,000,000                    
      foreign currency adjustments
    		62,000,000 38,000,000 -69,000,000 173,000,000 -12,000,000 -135,000,000 -97,000,000 -94,000,000 44,000,000 60,000,000 32,000,000 184,000,000 222,000,000 350,000,000 -204,000,000 338,000,000 -103,000,000     
      net realized and unrealized losses on cash equivalents, marketable securities, and other investments
    		-43,000,000 -32,000,000 17,000,000 8,000,000 29,000,000 18,000,000 163,000,000 51,000,000 153,000,000 7,974,000,000 5,454,000,000           
      stock compensation
    		275,000,000 121,000,000 107,000,000 275,000,000 126,000,000 110,000,000 238,000,000 100,000,000 59,000,000 170,000,000 67,000,000 43,000,000 183,000,000 41,000,000 29,000,000 38,000,000 -10,000,000     
      provision for deferred income taxes
    		212,000,000 -54,000,000 679,000,000 206,000,000 -28,000,000 -1,604,000,000 3,000,000 17,000,000 -353,000,000 -1,160,000,000 -1,053,000,000  345,000,000 427,000,000  702,000,000 -967,000,000     
      decrease in finance receivables
    		2,927,000,000 2,427,000,000 -1,560,000,000 -1,865,000,000 -1,121,000,000 -3,593,000,000 -1,473,000,000 -656,000,000 -3,959,000,000 -4,611,000,000 -2,192,000,000  10,465,000,000 2,699,000,000  -1,080,000,000 -1,238,000,000     
      decrease in accounts receivable and other assets
    		-3,500,000,000 -1,294,000,000 -451,000,000 -1,603,000,000 -806,000,000 345,000,000 -1,793,000,000 -732,000,000 1,187,000,000 -1,856,000,000 -956,000,000  -905,000,000 -588,000,000  39,000,000 207,000,000     
      decrease in inventory
    		-1,476,000,000 -2,677,000,000 2,365,000,000 -1,845,000,000 -3,154,000,000 3,010,000,000 -3,354,000,000 -1,967,000,000 1,584,000,000 -2,507,000,000 -2,755,000,000  -2,929,000,000 -2,176,000,000  -1,177,000,000 1,996,000,000     
      increase in accounts payable and accrued and other liabilities
    		7,293,000,000 3,020,000,000 -961,000,000 5,269,000,000 3,333,000,000 634,000,000 6,134,000,000 2,323,000,000 -1,185,000,000 3,180,000,000 1,714,000,000  -6,438,000,000 193,000,000  194,000,000 34,000,000     
      other
    		213,000,000 32,000,000 89,000,000 -309,000,000 41,000,000 369,000,000 165,000,000 95,000,000 79,000,000 118,000,000 132,000,000 -158,000,000 -233,000,000 -92,000,000 25,000,000 -202,000,000 85,000,000 -1,062,000,000 73,000,000 44,000,000 -18,000,000 
      net cash from operating activities
    		9,996,000,000 3,679,000,000 3,028,000,000 6,893,000,000 1,385,000,000 2,492,000,000 7,835,000,000 2,800,000,000 1,178,000,000 1,863,000,000 -1,084,000,000  5,248,000,000 4,492,000,000  -473,000,000 2,900,000,000 7,421,000,000 4,461,000,000 1,006,000,000 6,226,000,000 
      cash flows from investing activities
    		                     
      capital spending
    		-3,906,000,000 -1,818,000,000 -2,498,000,000 -4,194,000,000 -2,094,000,000 -2,295,000,000 -3,729,000,000 -1,780,000,000 -2,065,000,000 -3,069,000,000 -1,370,000,000 -1,772,000,000 -2,881,000,000 -1,368,000,000 -1,531,000,000 -1,780,000,000 -2,274,000,000 -1,872,000,000 -3,505,000,000 -1,786,000,000  
      acquisitions of finance receivables and operating leases
    		-24,438,000,000 -11,611,000,000 -14,778,000,000 -29,542,000,000 -14,829,000,000 -14,343,000,000 -26,231,000,000 -12,543,000,000 -12,545,000,000 -20,749,000,000 -10,278,000,000 -13,686,000,000 -23,959,000,000 -11,695,000,000 -12,428,000,000 -12,184,000,000 -14,434,000,000     
      collections of finance receivables and operating leases
    		22,542,000,000 10,983,000,000 11,304,000,000 22,530,000,000 11,238,000,000 10,835,000,000 22,517,000,000 11,170,000,000 10,600,000,000 24,139,000,000 11,988,000,000 12,654,000,000 26,782,000,000 12,482,000,000 12,210,000,000 12,709,000,000 12,328,000,000     
      purchases of marketable securities and other investments
    		-4,440,000,000 -2,433,000,000 -3,799,000,000 -6,069,000,000 -2,985,000,000 -2,691,000,000 -4,860,000,000 -2,545,000,000 -3,343,000,000 -8,065,000,000 -4,319,000,000 -4,248,000,000 -17,593,000,000 -11,580,000,000 -12,223,000,000 -8,244,000,000 -5,105,000,000     
      sales and maturities of marketable securities and other investments
    		5,593,000,000 3,617,000,000 1,735,000,000 6,812,000,000 3,579,000,000 2,316,000,000 7,584,000,000 4,413,000,000 2,909,000,000 11,257,000,000 7,115,000,000 4,790,000,000 23,853,000,000 11,686,000,000 7,993,000,000 4,998,000,000      
      settlements of derivatives
    		-104,000,000 -180,000,000 -94,000,000 -237,000,000 -184,000,000 69,000,000 -32,000,000 -41,000,000 -139,000,000 156,000,000 212,000,000 -28,000,000 -205,000,000 31,000,000 84,000,000 131,000,000 -277,000,000 224,000,000 29,000,000 70,000,000 103,000,000 
      capital contributions to equity method investments
    		-138,000,000 -3,000,000 -123,000,000 -1,299,000,000 -639,000,000 -1,118,000,000 -1,047,000,000 -699,000,000              
      returns of capital from equity method investments
    		1,700,000,000 1,700,000,000                    
      net cash from investing activities
    		-3,011,000,000 210,000,000 -6,861,000,000 -11,921,000,000 -5,880,000,000 -7,409,000,000 -6,157,000,000 -1,977,000,000 -4,972,000,000 4,142,000,000 3,315,000,000  6,178,000,000 -491,000,000  -3,114,000,000 -5,350,000,000 -24,000,000,000 -908,000,000 991,000,000 2,823,000,000 
      cash flows from financing activities
    		                     
      cash payments for dividends and dividend equivalents
    		-1,793,000,000 -1,196,000,000 -596,000,000 -1,925,000,000 -1,326,000,000 -601,000,000 -3,794,000,000 -3,193,000,000 -599,000,000 -807,000,000 -405,000,000 -400,000,000 -3,000,000 -3,000,000 0 -596,000,000 -595,000,000     
      purchases of common stock
    		  -150,000,000 -244,000,000             0 0 -91,000,000   
      net changes in short-term debt
    		-1,110,000,000 -564,000,000 957,000,000 -1,008,000,000 -1,201,000,000 -597,000,000 -658,000,000 -2,211,000,000 3,810,000,000 595,000,000 -614,000,000 1,705,000,000 890,000,000 273,000,000 524,000,000 -622,000,000 -290,000,000 1,261,000,000 29,000,000 49,000,000  
      proceeds from issuance of long-term debt
    		20,469,000,000 11,979,000,000 13,733,000,000 28,960,000,000 16,488,000,000 15,077,000,000 26,401,000,000 13,912,000,000 12,615,000,000 18,868,000,000 12,489,000,000 8,601,000,000 11,688,000,000 6,931,000,000 11,575,000,000 26,691,000,000 11,899,000,000     
      payments of long-term debt
    		-24,828,000,000 -16,223,000,000 -10,117,000,000 -25,145,000,000 -14,225,000,000 -10,146,000,000 -22,213,000,000 -12,242,000,000 -8,260,000,000 -24,697,000,000 -12,975,000,000           
      net cash from financing activities
    		-7,408,000,000 -6,120,000,000 3,790,000,000 384,000,000 -458,000,000 3,383,000,000 -461,000,000 -3,874,000,000 7,055,000,000 -6,240,000,000 -1,661,000,000  -14,198,000,000 -7,793,000,000  12,454,000,000 -689,000,000 17,400,000,000 -1,900,000,000 -1,363,000,000 -7,005,000,000 
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    		483,000,000 118,000,000 -493,000,000 -240,000,000 -171,000,000 10,000,000 66,000,000 70,000,000 358,000,000 -368,000,000 -24,000,000 -77,000,000 -1,000,000 -93,000,000 385,000,000 -448,000,000 199,000,000     
      net increase in cash, cash equivalents, and restricted cash
    		60,000,000 -2,113,000,000 -536,000,000 -4,884,000,000 -5,124,000,000 -1,524,000,000 1,283,000,000 -2,981,000,000 3,619,000,000 -603,000,000 546,000,000  -2,773,000,000 -3,885,000,000  8,419,000,000 -2,940,000,000     
      cash, cash equivalents, and restricted cash at beginning of period
    		23,190,000,000 23,190,000,000 0 25,110,000,000 25,110,000,000 0 25,340,000,000 25,340,000,000 0 20,737,000,000 20,737,000,000 0 25,935,000,000 25,935,000,000 0 17,741,000,000 0     
      cash, cash equivalents, and restricted cash at end of period
    		23,250,000,000 21,077,000,000 -536,000,000 20,226,000,000 19,986,000,000 -1,524,000,000 26,623,000,000 22,359,000,000 3,619,000,000 20,134,000,000 21,283,000,000 -6,887,000,000 23,162,000,000 22,050,000,000 1,463,000,000 26,160,000,000 -2,940,000,000     
      first half
    		                     
      first quarter
    		                     
      proceeds from sale of business
    		        14,000,000   0 144,000,000 7,000,000 0 1,340,000,000     144,000,000 
      equity method investment dividends received in excess of losses and impairments
    		   -124,000,000 -154,000,000 38,000,000 142,000,000 -7,000,000 349,000,000 171,000,000 199,000,000           
      losses on extinguishment of debt
    		        0             
      net loss on changes in investments in affiliates
    		     10,000,000 -17,000,000 -4,000,000 10,000,000 146,000,000 125,000,000  -332,000,000 -166,000,000  -15,000,000 17,000,000     
      held-for-sale impairment charges
    		              2,000,000 3,000,000 5,000,000     
      brazil manufacturing exit non-cash charges
    		                     
      held for sale impairment charges
    		                     
      pension and other post-retirement employee benefits
    		         -400,000,000 -213,000,000   -318,000,000 1,481,000,000       
      equity investment dividends received in excess of losses
    		            52,000,000 68,000,000  118,000,000      
      net income/
    		                     
      increase/(decrease) in benefit from credit and insurance losses
    		                     
      equity investment dividends received in excess of (earnings)/losses
    		                     
      net unrealized
    		                     
      net
    		                     
      benefit from deferred income taxes
    		                     
      decrease/
    		                     
      decrease/(increase) in accounts receivable and other assets
    		                     
      decrease/(increase) in inventory
    		                     
      increase/(decrease) in accounts payable and accrued and other liabilities
    		                     
      net cash provided by/(used in) operating activities
    		                     
      net cash provided by/(used in) investing activities
    		                     
      principal payments on long-term debt
    		            -26,683,000,000 -14,892,000,000 -9,873,000,000 -12,948,000,000 -11,650,000,000     
      net cash provided by/(used in) financing activities
    		                     
      net increase/(decrease) in cash, cash equivalents, and restricted cash
    		                     
      net unrealized loss on other investments
    		            -917,000,000 -914,000,000        
      benefit from credit and insurance losses
    		                     
      net (gain)/loss on changes in investments in affiliates
    		                     
      pension and other post-retirement employee benefits (“opeb”) expense
    		               -178,000,000      
      pension and other postretirement employee benefits (“opeb”) expense
    		                     
      sales and maturities of marketable and other investments
    		                     
      equity investment losses in excess of dividends received
    		                     
      purchases of marketable and other securities
    		                     
      sales and maturities of marketable and other securities
    		                     
      cash, cash equivalents, and restricted cash at january 1
    		                     
      cash, cash equivalents, and restricted cash at march 31
    		                     
      cash dividends
    		                 -595,000,000 -1,190,000,000 -593,000,000  
      cash, cash equivalents, and restricted cash at september 30
    		                     
      cash, cash equivalents, and restricted cash at june 30
    		                     
      purchases of equity and debt securities
    		                     
      sales and maturities of equity and debt securities
    		                     
      proceeds from issuance of other debt
    		                 48,245,000,000 581,000,000 172,000,000 18,513,000,000 
      principal payments on other debt
    		                 -31,413,000,000 -1,006,000,000 -778,000,000 -26,292,000,000 
      effect of exchange rate changes on cash and cash equivalents
    		                 -512,000,000 -90,000,000 -127,000,000  
      net increase/(decrease) in cash and cash equivalents
    		                     
      cash and cash equivalents at january 1
    		                 6,190,000,000 4,567,000,000 4,567,000,000 14,805,000,000 
      cash and cash equivalents at june 30
    		                  6,130,000,000  17,472,000,000 
      cash and cash equivalents at march 31
    		                   5,074,000,000  
      pension and opeb expense
    		                     
      net change in wholesale and other receivables
    		                     
      purchases of marketable securities
    		                 -19,531,000,000 -14,583,000,000 -7,161,000,000  
      sales and maturities of marketable securities
    		                 16,130,000,000 17,050,000,000 9,785,000,000  
      change related to venezuelan operations
    		                     
      proceeds from sales of retail finance receivables
    		                     
      net increase in cash and cash equivalents
    		                 309,000,000 1,563,000,000 507,000,000 2,676,000,000 
      cash and cash equivalents at december 31
    		                     
      investing activity
    		                  28,000,000 39,000,000  
      interest supplements and residual value support from automotive
    		                     
      financing activity to/
    		                     
      cash and cash equivalents at september 30
    		                     
      balance at december 31, 2014
    		                  40,000,000 40,000,000  
      other comprehensive income, net of tax
    		                     
      common stock issued
    		                  1,000,000 1,000,000  
      treasury stock/other
    		                     
      cash dividends declared
    		                     
      balance at september 30, 2015
    		                     
      balance at december 31, 2013
    		                  40,000,000 40,000,000  
      balance at september 30, 2014
    		                     
      balance at june 30, 2015
    		                  41,000,000   
      balance at june 30, 2014
    		                  40,000,000   
      balance at march 31, 2015
    		                   41,000,000  
      balance at march 31, 2014
    		                   40,000,000  
      cash flows from operating activities of continuing operations
    		                     
      cash flows from investing activities of continuing operations
    		                     
      purchases of securities
    		                    -41,761,000,000 
      sales and maturities of securities
    		                    46,680,000,000 
      cash change due to initial consolidation of businesses
    		                     
      cash flows from financing activities of continuing operations
    		                     
      changes in short-term debt
    		                    662,000,000 
      capital expenditures
    		0 0 0 0 0 0 0 0 0 0 0  0 0  0 0 0 0 0 -2,022,000,000 
      free cash flows
    		9,996,000,000 3,679,000,000 3,028,000,000 6,893,000,000 1,385,000,000 2,492,000,000 7,835,000,000 2,800,000,000 1,178,000,000 1,863,000,000 -1,084,000,000  5,248,000,000 4,492,000,000  -473,000,000 2,900,000,000 7,421,000,000 4,461,000,000 1,006,000,000 4,204,000,000 
      acquisitions of retail and other finance receivables and operating leases
    		                    -17,355,000,000 
      collections of retail and other finance receivables and operating leases
    		                    17,052,000,000 
      elimination of cash balances upon disposition of discontinued/held-for-sale operations
    		                     
      sales of common stock
    		                     
      payments on notes/transfer of cash equivalents to the uaw voluntary employee benefit association ("veba") trust
    		                     
      effect of exchange rate changes on cash
    		                    632,000,000 
      cash and cash equivalents of held-for-sale operations at january 1
    		                     
      less: cash and cash equivalents of held-for-sale operations at june 30
    		                    9,000,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.